For individuals with BMI above 30 or BMI above 27 with comorbidities, FDA-approved GLP-1 receptor agonists (semaglutide, tirzepatide) have far stronger evidence and produce dramatically greater weight loss
(India), Lupin Limited (India), Zydus Lifesciences (India), Torrent Pharmaceuticals (India), Glenmark Pharmaceuticals (India), Alkem Laboratories (India), Natco Pharma (India), MSN Laboratories (India), Eris Lifesciences (India), Emcure Pharmaceuticals (India), Samsung Bioepis Co., Ltd
This pattern is consistent with reduced inflammatory signaling at the vascular interface and fewer cues for sustained endothelial activation, suggesting improved vascular stability
Early research suggests that L-carnitine can improve exercise performance in people with chronic obstructive pulmonary disease (COPD)
Release is safe for use alongside medications, including those for type 2 diabetes and offers a safe and holistic solution for sustainable weight loss and improved overall health